Revance Therapeutics Inc (RVNC)

[iwfal]

>>There is no error;<<

The actual text of the letter (??) is conspicuously missing any mention of duration. Just ‘after injection’. Undoubtedly they will claim they meant after 24 weeks, but as a hit piece that won’t get traction with the FDA anyway, better to just leave it out.

I write today to express serious concern about the overwhelming evidence that Revance Therapeutics, Inc. is engaging in public advertising by deceiving consumers regarding the efficacy of their neuromodulator DAXXIFY. While FDA testing found roughly one-third (33 percent) of patients had no or mild facial lines after injection, the Revance Therapeutics press release puts this figure at 50 percent, which is a misstatement of the FDA’s empirical findings.